TRANSDERMAL COMPOSITION COMPRISING ROTIGOTINE
The present invention relates to a method for preparing a transdermal preparation comprising rotigotine as an active ingredient, and more particularly, to a method for preparing a transdermal preparation, comprising a step of mixing rotigotine and an ethylene-vinyl acetate adhesive at a weight ratio...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a method for preparing a transdermal preparation comprising rotigotine as an active ingredient, and more particularly, to a method for preparing a transdermal preparation, comprising a step of mixing rotigotine and an ethylene-vinyl acetate adhesive at a weight ratio of 1:0.1 to 20. Further, the present invention relates to a transdermal preparation prepared by the method and a transdermal therapeutic system. The preparation and system of the present invention prevent the precipitation of rotigotine to improve the long-term storage stability and effectively release the rotigotine, and thus can be effectively applied in the preparation of rotigotine-containing patches. [Reference numerals] (AA) Sample 1; (BB) Sample 2; (CC) Sample 3; (DD) Sample 4 |
---|